• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Zai Lab Limited - American Depositary Shares (NQ:ZLAB)

    18.42 -0.80 (-4.16%)
    Streaming Delayed Price Updated: 4:00 PM EST, Mar 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Zai Lab Limited - American Depositary Shares

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    News headline image
    Nuvation Bio (NUVB) Soars on IBTROZI's Blockbuster Launch and Stellar Q3 2025 Performance
    Boston, MA – November 19, 2025 – Nuvation Bio Inc. (NASDAQ: NUVB) has captured the financial spotlight, witnessing a remarkable 47.71% surge in its stock price following a stellar third-quarter 2025... 
    Via MarketMinute
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
     
    Via Benzinga
    News headline image
    Zai Lab's Double Whammy: Earnings Miss, Phase 3 Setback ↗
     
    Via Benzinga
    Topics Earnings
    News headline image
    China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order ↗
    Zai Labs and BeOne Medicines plummeted Wednesday on reports an executive order could reduce access to China-developed drugs. 
    Via Investor's Business Daily
    Topics Government
    Zai Lab To Await More Trial Data Before Filing For Regulatory Approval For Experimental Cancer Drug ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For August 7, 2025 ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For May 8, 2025 ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For February 27, 2025 ↗
     
    Via Benzinga
    News headline image
    Why Zai Lab (ZLAB) Stock Is Trading Higher ↗
    Zai Lab shares are trading higher by 4% during Friday's session. The company priced a $200 million public offering. 
    Via Benzinga
    News headline image
    Earnings Scheduled For November 12, 2024 ↗
     
    Via Benzinga
    News headline image
    Amgen Faces Setback As Final Data Weakens Case For Gastric Cancer Drug ↗
    Amgen and Zai Lab's Phase 3 trial of bemarituzumab in gastric cancer showed a weaker survival benefit, shifting focus to the upcoming FORTITUDE-102 results. 
    Via Benzinga
    News headline image
    C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Netflix, BlackSky Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Amgen's Gastric Cancer Drug Improves Survival In Phase 3, Notes Ocular Side Effects ↗
    Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected later. 
    Via Benzinga
    News headline image
    ZAI LAB LTD-ADR (NASDAQ:ZLAB) – A High-Growth Biotech Stock Meeting Minervini’s Criteria ↗
    ZAI LAB LTD-ADR (NASDAQ:ZLAB) is a high-growth biotech stock meeting Minervini’s Trend Template with strong revenue growth, technical strength, and sector leadership. 
    Via Chartmill
    News headline image
    Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio? ↗
     
    Via Benzinga
    News headline image
    Guidewire Software Posts Upbeat Q3 Results, Joins Yext, REV Group And Other Big Stocks Moving Higher On Wednesday ↗
     
    Via Benzinga
    News headline image
    Wednesday's session: gap up and gap down stocks ↗
    In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down. 
    Via Chartmill
    News headline image
    NovoCure's Tumor Treating Fields Boost One-Year And Pain-Free Survival In Pancreatic Cancer Trial ↗
    TTField therapy with chemotherapy improved median overall and pain-free survival in pancreatic cancer, according to new data from the PANOVA-3 trial. 
    Via Benzinga
    News headline image
    Hertz Global And Webull Stocks Are Among Top Mid-Cap Gainers Last Week (Apr 14-Apr 18): Are The Others In Your Portfolio? ↗
    Top mid-cap performers last week: Webull Corp, Hertz Global, Metsera Inc, Vista Energy, Certara Inc, Sibanye-Stillwater, Banco Macro, Grupo Financiero Galicia, Banco BBVA Argentina, Recursion... 
    Via Benzinga
    News headline image
    Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday ↗
     
    Via Benzinga
    News headline image
    Why ZAI LAB LTD-ADR (NASDAQ:ZLAB) could fit Mark Minervini’s high-growth criteria ↗
    A fundamental and technical analysis of (NASDAQ:ZLAB): Why the high growth investor may take a look at ZAI LAB LTD-ADR (NASDAQ:ZLAB). 
    Via Chartmill
    News headline image
    No Fear And No Panic After A 10% Correction = No Bottom ↗
    In this video lesson, I discuss the overall market, my books, and my game plan moving forward after Friday's ugly sell-off. 
    Via Talk Markets
    Topics Stocks / Equities
    News headline image
    Argan Posts Upbeat Results, Joins KULR Technology, Abacus Global Management, W. R. Berkley And Other Big Stocks Moving Higher On Friday ↗
     
    Via Benzinga
    News headline image
    Concentrix Posts Better-Than-Expected Earnings, Joins Soleno Therapeutics, Petco Health and Wellness, MillerKnoll And Other Big Stocks Moving Higher On Thursday ↗
     
    Via Benzinga
    News headline image
    NovoCure Q4 EPS Misses, Revenue Matches ↗
    NovoCure reported a solid jump in revenue, but earnings fell short due to rising costs and adoption challenges. 
    Via The Motley Fool
    News headline image
    Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday ↗
     
    Via Benzinga
    News headline image
    Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025? ↗
    Via The Motley Fool
    News headline image
    NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients ↗
    NovoCure and Zai Lab report PANOVA-3 trial success with TTFields therapy, achieving significant survival benefits for pancreatic cancer patients. 
    Via Benzinga
    News headline image
    Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday ↗
     
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.